ProCE Banner Activity

CROI 2019 Results From 2 Randomized Trials Evaluating INSTI-Based ART Initiation During Pregnancy: Implications for HIV Care in France

Conference Coverage
Clinical Thought
New data reported at CROI 2019 demonstrate improved virologic outcomes and comparable safety with RAL or DTG vs EFV initiated during the second or third trimesters of pregnancy. What do these results mean for HIV care providers treating woman during pregnancy in France?

Released: July 18, 2019

Expiration: July 16, 2020

No longer available for credit.

Share

Faculty

Karine Lacombe

Karine Lacombe, MD, PhD

Professor of Medicine
Infectious Diseases Department
Sorbonne Uiversité
Inserm Pierre Louis School of Public Health
Paris, France

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

This program is supported by independent educational grants from

Gilead Text

ViiV Healthcare

Faculty Disclosure

Primary Author

Karine Lacombe, MD, PhD

Professor of Medicine
Infectious Diseases Department
Sorbonne Uiversité
Inserm Pierre Louis School of Public Health
Paris, France

Karine Lacombe, MD, PhD, has no relevant conflicts of interest to report.